Showing results (31-40 of 369) with videos related to
Sort By:
Pageof 37
Trends in Cancer|March 12, 2022
Optimizing the future: how mathematical models inform treatment schedules for cancerDeepti Mathur, Ethan Barnett, Howard I Scher, et al.Nature Reviews. Clinical Oncology|March 6, 2013
Validation and clinical utility of prostate cancer biomarkersHoward I Scher, Michael J Morris, Steven Larson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Quantifying the amount of variation in survival explained by prostate-specific antigenDavid A Verbel, Glenn Heller, William K Kelly, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapySusan F Slovin, Andrew S Wilton, Glenn Heller, et al.Nature Reviews. Clinical Oncology|May 21, 2014
High-risk prostate cancer-classification and therapyAlbert J Chang, Karen A Autio, Mack Roach, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2011
Adaptive clinical trial designs for simultaneous testing of matched diagnostics and therapeuticsHoward I Scher, Shelley Fuld Nasso, Eric H Rubin, et al.Nature Clinical Practice. Oncology|December 2, 2006
Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trialsMark T Fleming, Michael J Morris, Glenn Heller, et al.Plos One|October 14, 2015
Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression ModelHoward I Scher, Kirk Solo, Jason Valant, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancerFrancis M Sirotnak, Yohung She, Fei Lee, et al.Nature Communications|January 20, 2011
Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signallingVinagolu K Rajasekhar, Lorenz Studer, William Gerald, et al.Pageof 37